Molnupirivir

[anonymous]

Beaten again by Pfizer ! They start after us and get approval first with better data. First embarrassing effort on Covid vaccine and now this

 

[anonymous]

Beaten again by Pfizer ! They start after us and get approval first with better data. First embarrassing effort on Covid vaccine and now this

A big FU Merck!

why would the FDA approve our garbage?

A big thank you to our MRL division got failing again.

 

[anonymous]

Beaten again by Pfizer ! They start after us and get approval first with better data. First embarrassing effort on Covid vaccine and now this

Yes, Pfizer beat the crap out of Merck again. Perhaps that front porch rocker looks more and more tempting for Dean Li. He lis a little young for retirement, but he really needs to up his game asap.

 

[anonymous2]

I would not want to sell that product.

 

[anonymous]

Yes, Pfizer beat the crap out of Merck again. Perhaps that front porch rocker looks more and more tempting for Dean Li. He lis a little young for retirement, but he really needs to up his game asap.

Dean Li is in over his head...

 

[anonymous]

I would not want to sell that product.

Who cares. I would sell it if it’s a sugar pill. There is no right or wrong. Maybe it will work, then again maybe not. As long as I get paid.

 

[anonymous]

I would not want to sell that product.

I hope you get fired!

 

[anonymous]

I hope you have to sell it.
2022 career killer!

 

[anonymous]

Good luck selling any of his in US, unless there is a supply shortage of the Pfizer drug

 

[anonymous]

Good luck selling any of his in US, unless there is a supply shortage of the Pfizer drug

This is the deal. There is supply shortage of the Pfizer drug during the coming 6-8 months. This is the window of opportunity for Mercks second rate drug.